Anticancer agents: Tumor cell growth inhibitory activity and binary QSAR analysis

被引:9
作者
Ren, SS [1 ]
Lien, EJ [1 ]
机构
[1] Univ So Calif, Sch Pharm, Dept Pharmaceut Sci, Los Angeles, CA 90089 USA
关键词
anticancer agents; binary QSAR; molecular weight; QSAR; and tumor cell growth inhibitory activity;
D O I
10.2174/1381612043384925
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The tumor cell growth inhibitory activities (log 1/GI(50)) of 166 anticancer agents studied at the National Cancer Institute (NCI) in vitro anticancer screening program have allowed us to analyze the relative importance of physicochemical parameters in influencing the inhibitory activities. Increased molecular weight, as measured by the logarithm Of molecular weight (log MW), is found to be an important contributor to the tumor cell growth inhibitory activities. The tumor cell growth inhibitory activities in different subpanels of the tumor cells are highly inter-correlated with each other. A simple binary quantitative structure-activity relationship (QSAR) model was derived from the 166 anticancer drugs, based oil the tumor cell growth inhibitory activities transformed into a binary (active or inactive) data format. The model obtained call be tested with additional new data, and may be useful to identify active compounds from a large compound library to be included in high throughput screening.
引用
收藏
页码:1399 / 1415
页数:17
相关论文
共 26 条
[1]   The role of cyclooxygenase inhibitors in cancer prevention [J].
Anderson, WF ;
Umar, A ;
Viner, JL ;
Hawk, ET .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (12) :1035-1062
[2]  
BOYD MR, 1992, DEV ONCOL, V68, P11
[3]   Descriptors, physical properties, and drug-likeness [J].
Brüstle, M ;
Beck, B ;
Schindler, T ;
King, W ;
Mitchell, T ;
Clark, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (16) :3345-3355
[4]  
COTY C, 2002, DRUG DISCOVERY DEV, V5, P67
[5]   Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties [J].
Ertl, P ;
Rohde, B ;
Selzer, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) :3714-3717
[6]   Binary quantitative structure-activity relationship (QSAR) analysis of estrogen receptor ligands [J].
Gao, H ;
Williams, C ;
Labute, P ;
Bajorath, J .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1999, 39 (01) :164-168
[7]  
Labute P, 1999, Pac Symp Biocomput, P444
[8]  
Leo A, 1995, EXPLORING QSAR FUNDA
[9]  
Lien E J, 1985, Prog Drug Res, V29, P67
[10]  
Lien E. J., 1987, SAR SIDE EFFECTS DRU